Business Description
The Company entered into an exclusive memorandum of understanding with Immunovative
Clinical Research, Inc. (“ICRI”), a Nevada corporation and wholly-owned
subsidiary of Immunovative Therapies, Ltd. (“ITL”), an Israeli corporation
pursuant to which the Company and ICRI intended to pursue a merger resulting
in Novo owning ICRI.
Green Innovations
On May 31, 2013, the Company signed an exclusive North American license agreement
with Green Innovations, Inc. (“Green Innovations”) for the commercialization
of Bamboo-Based “100% Tree Free” products including hospital grade
biodegradable disinfectant wipes. This 5-year license agreement functioned such
that profits were to be split equally between Tauriga and Green Innovations.
Bacterial Robotics
On October 29, 2013, the Company entered into a strategic alliance with Bacterial
Robotics, LLC (“Bacterial Robotics”). Bacterial Robotics owns certain
patents and/or other intellectual property related to the development of genetically
modified micro-organisms (GMOs) and GMOs tailored to perform one or more specific
functions, one such GMO being adopted to clean polluting molecules from nuclear
waste, such GMO being referred herein as the existing BactoBot Technology (the
BR Technology). Bacterial Robotics is developing a whitepaper to deliver to
the Company for acceptance. Upon acceptance by the Company, the parties will
form a strategic relationship through the formation of a joint venture in which
the Company will be the majority and controlling owner which will use the NuclearBot
Technology to further the growth of the nuclear wastewater treatment market.
The intent is for Bacterial Robotics to issue a 10-year license agreement.
Pilus Energy
On November 25, 2013, the Company entered a definitive agreement to acquire
Cincinnati, Ohio based Pilus Energy LLC (“Pilus Energy”), a developer
of alternative cleantech energy platforms using proprietary microbial solutions
that creates electricity while consuming polluting molecules from wastewater.
Upon consummation of the proposed transaction, which has been unanimously ratified
by Tauriga’s board of directors, Pilus Energy will become a wholly-owned
subsidiary of Tauriga. In addition, certain advisors of Pilus Energy will be
incorporated into the existing management team of Tauriga and report directly
to the Company’s Chief Executive Officer. A total of $100,000 was paid
by Tauriga to Bacterial Robotics in connection with the execution of this November
2013 definitive agreement for the acquisition of Pilus Energy.